Today, Kamux’s Pajuharju commented on the company’s market value, saying that if you look at what they have in inventory and how much debt they have, the stock is currently quite cheap. (At 1:04:30)
Biohit’s Jussi Hahtela also made a similar comment at the end of this presentation, as mentioned above, stating that compared to the stock’s historical valuation, the share is currently trading below it.
Do those comments provide any added value for the investor? Everyone can decide for themselves.